Delhi High Court Sets Aside Centre's Decision Banning Sale Of Oxytocin

In August, the court had suspended till September 30 the central government's prohibition on sale and manufacture of oxytocin by private companies till December 30.

5 Shares
EMAIL
PRINT
COMMENTS
Delhi High Court Sets Aside Centre's Decision Banning Sale Of Oxytocin

The court said there was no logic behind decision to restrict supply of oxytocin. (Representational)


New Delhi: 

The Delhi High Court Friday set aside the government decision to ban private firms from producing and selling oxytocin, a drug used for inducing labour contractions and controlling bleeding.

A bench of Justices S Ravindra Bhat and AK Chawla said the government's decision was arbitrary and unreasonable.

The bench also said that there was no scientific basis behind the Centre's decision restricting private companies from making or supplying the drug, which helps new mothers lactate, to prevent its alleged misuse in the dairy sector for increasing milk production.

As per the Centre's April 27 notification, the state-run Karnataka Antibiotics and Pharmaceuticals Ltd (KAPL) was solely allowed by the Centre to make the drug to meet the country's needs.

The high court on August 31 had suspended till September 30 the central government's prohibition on sale and manufacture of oxytocin by private companies for domestic use. The stay was later extended till December 15

 

 



Get the latest election news, live updates and election schedule for Lok Sabha Elections 2019 on ndtv.com/elections. Like us on Facebook or follow us on Twitter and Instagram for updates from each of the 543 parliamentary seats for the 2019 Indian general elections.

NDTV Beeps - your daily newsletter

................................ Advertisement ................................

................................ Advertisement ................................

................................ Advertisement ................................